MedTrace Logo

To Demonstrate the Effect of Food on the Bioavailability of Glipizide

NCT00947024 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2017-03-28

No results posted yet for this study

Summary

To demonstrate the effect of food on the bioavailability of Glipizide.

Conditions

Interventions

DRUG

10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After a Standard Breakfast.

DRUG

10 mg Glucotrol Tablet (Roerig), Administered Immediately After a Standard Breakfast.

DRUG

10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered After an Overnight Fast.

Sponsors & Collaborators

Principal Investigators

  • Roger D. Anderson, M.D. · Novum Pharmaceutical Research Services

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1993-11-30
Primary Completion
1993-11-30
Completion
1993-11-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00947024 on ClinicalTrials.gov